Skip to content

MedS&P AS

Registry code (registrikood) 12327901Public limited company (Aktsiaselts)VAT EE101647524Activity (EMTAK 46462): Meditsiiniseadmete ja kirurgiriistade ning ortopeediliste abivahendite hulgimüükActive

Tallinn, Harju County · Financial data: annual reports up to 2025; tax data up to 2026 Q3

Revenue (2025)
€2.6M
▼ 52.5% vs 2024
Profit before tax (2025)
-€373k
Employees, FTE (2025)
6
State taxes paid, last 4 quarters
€103k

Revenue, profit and employees, 2019–2025

€5.3M2019€4.9M2020€2.5M2021€3.5M2022€4.0M2023€5.5M2024€2.6M2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2019€5,278,529€7,165€3,106€1,301,5302
2020€4,854,691-€427,021-€432,369€843,7104
2021€2,499,348€260,638€256,143€1,073,5254
2022€3,469,825€401,574€393,043€1,434,8896
2023€3,974,898-€289,926-€303,950€1,099,0796
2024€5,512,948€766,661€678,529€1,735,6256
2025€2,620,175-€343,432-€384,524€1,311,1016

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2019€215,782€2,970,114€1,668,584—€1,301,530
2020€470,448€1,494,198€650,488—€843,710
2021€512,159€1,366,752€293,227—€1,073,525
2022€336,878€2,000,158€565,269—€1,434,889
2023€561,935€1,549,301€450,222—€1,099,079
2024€188,945€2,174,523€438,898—€1,735,625
2025€627,109€2,632,023€1,320,922—€1,311,101

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2022 Q1€15,295€11,116€889,8814
2022 Q2€9,214€9,644€1,823,5546
2022 Q3€11,494€12,015€883,5266
2022 Q4€10,088€10,545€2,633,6036
2023 Q1€20,139€15,346€2,730,1946
2023 Q2€10,557€10,933€2,649,7696
2023 Q3€14,176€14,665€1,055,7956
2023 Q4€22,876€18,290€430,5116
2024 Q1€22,532€23,461€586,4626
2024 Q2€18,947€19,212€600,3846
2024 Q3€19,152€19,848€2,872,5716
2024 Q4€18,769€19,556€4,939,9096
2025 Q1€45,564€27,761€864,6316
2025 Q2€18,752€19,396€608,7766
2025 Q3€21,251€21,976€1,519,5506
2025 Q4€18,704€19,337€2,357,9445
2026 Q1€37,499€27,282€781,9695
2026 Q2€21,680€22,477€1,849,0484
2026 Q3€24,938€25,835€710,0905

Source: EMTA quarterly published data, as of 10 October 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 January 2025–31 December 2025), MedS&P AS reported revenue of €2,620,175.

The company recorded a net loss of €384,524 in the 2025 financial year.

Revenue decreased by 52.5% from €5,512,948 in 2024 to €2,620,175 in 2025.

Revenue grew at a compound annual rate of -11.0% between 2019 and 2025.

Equity accounted for 49.8% of total assets of €2,632,023 at the end of the 2025 reporting period.

With 6 full-time-equivalent employees in 2025, revenue per employee was €436,696.

Across the 4 most recent quarters declared to EMTA, up to Q3 2026, MedS&P AS reported €5,699,051 in turnover.

EMTA recorded 5 employees for the quarter ending Q3 2026, compared with 6 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-11-16. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.